Structured evidence table for Algal Oil Triglycerides Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Algal Oil Triglycerides Randomized Trial | It is imperative to develop a sustainable food system with a reduced environmental footprint [,,]. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Algal Oil Triglycerides Randomized Trial | We synthesize evidence on nutritional evaluation, application scenarios, and global regulatory differences, and analyze key bottlenecks. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Algal Oil Triglycerides Randomized Trial | These advances include improvements in cultivation systems such as closed photobioreactors and optimized open-pond systems that have enhanced biomass productivity and reduced contamination risks []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Algal Oil Triglycerides Randomized Trial | 1 2 3 4 According to United Nations projections, the global population is expected to continue growing over the next 50–60 years, peaking at approximately 10.3 billion around the mid-2080s []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Algal Oil Triglycerides Randomized Trial | 8 9 6 10 11 12–14 1 15 16 15 2 16 17 18 Most of the increased morbidity and mortality associated with CKD is attributable to CVD [,] with an increased risk beginning with both mildly reduced estimated glomerular filtration rate (eGFR) and very low levels of albuminuria (albumin: creatinine ratio >30 mg/g). | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Randomized Trial | This risk increases exponentially and independently with worsening eGFR and albuminuria with the highest risk being observed in individuals with severely reduced eGFR and high levels of albuminuria [,,]. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Randomized Trial | Not surprisingly, kidney failure, the most extreme category of CKD, is associated with the highest cardiovascular risk []. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Randomized Trial | 1–5 4–7 Chronic kidney disease (CKD) is a major global health priority estimated to affect 13% of adults worldwide including close to 100 million Europeans, and projected to increase rapidly over the next decades []. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
Source documents